Location: Palo Alto, CA
CIK: 0001306923 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $1.057B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,831,035 | $162M | 15.3% | $83.16 | +7.0% | COM | 09061G101 |
| INSM | INSMED INC | 5,889,491 | $149M | 14.1% | $17.79 | +28.5% | COM | 457669307 |
| UTHR | UNITED THERAPEUTICS CORP | 575,907 | $130M | 12.3% | $89.23 | +158.1% | COM | 91307C102 |
| FOLD | AMICUS THERAPEUTICS INC | 10,524,022 | $128M | 12.1% | $9.63 | +34.0% | COM | 03152W109 |
| BIIB | BIOGEN INC | 381,282 | $97.99M | 9.3% | $264.98 | +0.9% | COM | 09062X103 |
| PRTA | PROTHENA CORP PLC | 1,657,458 | $79.97M | 7.6% | $21.46 | +176.9% | COM | G72800108 |
| — | REVANCE THERAPEUTICS INC | 5,228,609 | $59.97M | 5.7% | $21.40 | — | COM | 761330109 |
| STAA | STAAR SURGICAL CO | 1,374,822 | $55.24M | 5.2% | $24.23 | +93.3% | COM | 852312305 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,405,793 | $50.14M | 4.7% | $28.41 | -4.4% | COM | 004225108 |
| — | SAGE THERAPEUTICS INC | 1,005,776 | $20.7M | 2.0% | $42.84 | — | COM | 78667J108 |
| EHTH | EHEALTH INC | 2,739,379 | $20.27M | 1.9% | $38.13 | -79.4% | COM | 28238P109 |
| ALGN | ALIGN TECHNOLOGY INC | 55,705 | $17.01M | 1.6% | $149.18 | +131.6% | COM | 016255101 |
| ALKS | ALKERMES PLC | 603,400 | $16.9M | 1.6% | $22.36 | +31.1% | COM | G01767105 |
| SRPT | SAREPTA THERAPEUTICS INC | 94,030 | $11.4M | 1.1% | $128.81 | -12.3% | COM | 803607100 |
| NVCR | NOVOCURE LTD | 660,275 | $10.66M | 1.0% | $58.84 | -51.0% | COM | G6674U108 |
| ANAB | ANAPTYSBIO INC | 431,224 | $7.745M | 0.7% | $19.06 | +0.1% | COM | 032724106 |
| — | KARYOPHARM THERAPEUTICS INC | 5,675,876 | $7.606M | 0.7% | $16.36 | — | COM | 48576U106 |
| — | NEVRO CORP | 386,832 | $7.435M | 0.7% | $22.21 | — | COM | 64157F103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 472,600 | $6.862M | 0.6% | $16.84 | +12.3% | COM | 87164F105 |
| GOSS | GOSSAMER BIO INC | 6,530,288 | $5.438M | 0.5% | $1.61 | -28.6% | COM | 38341P102 |
| CYTK | CYTOKINETICS INC | 111,717 | $3.291M | 0.3% | $6.71 | +396.1% | COM | 23282W605 |
| RLMD | RELMADA THERAPEUTICS INC | 732,400 | $2.197M | 0.2% | $3.27 | -9.2% | COM | 75955J402 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $2.045M | 0.2% | $15.56 | +76.0% | COM | 604749101 |
| TVTX | TRAVERE THERAPEUTICS INC | 166,069 | $1.485M | 0.1% | $23.56 | -40.1% | COM | 89422G107 |
| VNDA | VANDA PHARMACEUTICALS INC | 278,985 | $1.205M | 0.1% | $11.21 | -50.5% | COM | 921659108 |
| ALDX | ALDEYRA THERAPEUTICS INC | 160,800 | $1.074M | 0.1% | $7.10 | +4.6% | COM | 01438T106 |
| — | KEZAR LIFE SCIENCES INC | 656,200 | $781K | 0.1% | $5.16 | — | COM | 49372L100 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY I | 27,100 | $381K | 0.0% | $39.74 | -50.7% | COM | 87357P100 |
| URGN | UROGEN PHARMA LTD | 24,500 | $343K | 0.0% | $27.01 | -40.6% | COM | M96088105 |